Rakshamani Tripathi
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 11, 2023
ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization.Anastasia Lyon, Rakshamani Tripathi, Christina Meeks
|Oct 30, 2020
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling.Rakshamani Tripathi, Zulong Liu, Aditi Jain
|Feb 22, 2018
Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis.Rakshamani Tripathi, Leann S Fiore, Dana L Richards
Pageof 1